Students in leadership positions learn about brain tumors and gain real world experience in running a non-profit business while raising funds for brain tumor research. Beneficiaries of the money we raise are Barrow Neurological Institute, National Brain Tumor Society, Phoenix Children's Hospital, Translational Genomics Research Institute, and University of Arizona.

"Be the change you wish to see in the world..." Gandhi

Our Beneficiaries

  • University of AZ Research Centers
    University of AZ Research Centers
  • Quote 1 - Mohamed Al-Fayed

    “I will continue to distribute blankets, sleeping bags, warm clothing and food on a regular basis, in the hope that my modest efforts will give some comfort to those people we are able help.” — Mohamed Al-Fayed

  • “One of the great movements in my lifetime among educated people is the need to commit themselves to action. Most people are not satisfied with giving money; we also feel we need to work.”

    — Peter Drucker

Brain Tumor News

People suffering from two of our most deadly diseases may someday benefit from a new approach being studied at Virginia Tech. Glioblastoma, the deadliest form of brain cancer, and Alzheimer’s disease, the fifth largest killer of people over 65, share a similar disease process even though they’re very different conditions.

A group of University of Arizona researchers believe they've found an important clue in the fight against the kind of cancer that killed Sen. John McCain in August. That clue lies in the DNA found in the cells of long-term and short-term survivors of glioblastoma, an aggressive form of brain cancer.

Doctors usually use the biological characteristics of tumors to observe the progress and response to treatment, such as if there are gene mutations or malignant features. Previous studies have shown that identifying the biological characteristics may contribute to better treatment and may increase survival rates.

Optune, a skullcap developed in Israel that fights cancer using electric frequencies, has extended the lives of patients with glioblastoma, the most aggressive form of brain cancer, by months or even years.

Iranian scientists have managed to produce brain cancer vaccine, an expert in immunology whose company is involved in production of the vaccine has said.

Migraines and headaches often occur among patients with brain tumors and are the most common complaint as the initial symptoms among these patients. Based on their high prevalence, there has been speculation as to whether headaches and migraines should be treated as risk factors for the development of brain tumors or if they should be considered the “first sign” of brain tumors.

View Previous News Articles - Click Here!